Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Meier

Showing results (211-220 of 1,050) with videos related to

Pageof 105
Sort By:
Therapeutische Umschau. Revue Therapeutique|February 7, 1998
[Cholestatic liver diseases]C Reichel, P J Meier-Abt
The Lancet. Diabetes & Endocrinology|September 22, 2016
GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last?Michael A Nauck, Juris J Meier
Versicherungsmedizin|August 1, 1993
[Long-term follow-up of pulmonary emphysema]G Schultze-Werninghaus, J Meier-Sydow
Journal of Clinical Gastroenterology|March 11, 2005
Hepatocellular transporters and cholestasisChristiane Pauli-Magnus, Peter J Meier
Women & Health|January 1, 1994
State abortion funding policies in 1990D R McFarlane, K J Meier
Toxicon : Official Journal of the International Society on Toxinology|October 1, 1994
Studies on venom and venom apparatus of Fea's viper, Azemiops feaeD Mebs, U Kuch, J Meier
The Journal of Clinical Endocrinology and Metabolism|November 6, 2009
For insulinomas, no place to hideMichael A Nauck, Juris J Meier
Diabetologia|September 28, 2007
The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphismsM A Nauck, J J Meier
Diabetes Care|July 25, 2013
Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetesJuris J Meier, Riccardo C Bonadonna
The Lancet. Diabetes & Endocrinology|March 14, 2014
Pancreatitis and incretin-based drugs: clarity or confusion?Michael A Nauck, Juris J Meier
Pageof 105

Showing results (211-220 of 1,050) with videos related to

Sort By:
Pageof 105
Therapeutische Umschau. Revue Therapeutique|February 7, 1998
[Cholestatic liver diseases]C Reichel, P J Meier-Abt
The Lancet. Diabetes & Endocrinology|September 22, 2016
GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last?Michael A Nauck, Juris J Meier
Versicherungsmedizin|August 1, 1993
[Long-term follow-up of pulmonary emphysema]G Schultze-Werninghaus, J Meier-Sydow
Journal of Clinical Gastroenterology|March 11, 2005
Hepatocellular transporters and cholestasisChristiane Pauli-Magnus, Peter J Meier
Women & Health|January 1, 1994
State abortion funding policies in 1990D R McFarlane, K J Meier
Toxicon : Official Journal of the International Society on Toxinology|October 1, 1994
Studies on venom and venom apparatus of Fea's viper, Azemiops feaeD Mebs, U Kuch, J Meier
The Journal of Clinical Endocrinology and Metabolism|November 6, 2009
For insulinomas, no place to hideMichael A Nauck, Juris J Meier
Diabetologia|September 28, 2007
The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphismsM A Nauck, J J Meier
Diabetes Care|July 25, 2013
Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetesJuris J Meier, Riccardo C Bonadonna
The Lancet. Diabetes & Endocrinology|March 14, 2014
Pancreatitis and incretin-based drugs: clarity or confusion?Michael A Nauck, Juris J Meier
Pageof 105